Tag | Content |
---|
EnhancerAtlas ID | HS109-02838 |
Organism | Homo sapiens |
Tissue/cell | Kasumi-1 |
Coordinate | chr10:45871170-45872610 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
RREB1 | MA0073.1 | chr10:45871778-45871798 | GGGCGGGGGGTGGTTGGGGG | - | 9.17 | SPI1 | MA0080.4 | chr10:45871919-45871933 | TACTTCCTCATTCT | - | 6.18 | SPIC | MA0687.1 | chr10:45871433-45871447 | TACTTCCCCTTTGT | - | 6.47 | SPIC | MA0687.1 | chr10:45871919-45871933 | TACTTCCTCATTCT | - | 6.87 | ZNF263 | MA0528.1 | chr10:45871457-45871478 | TCCTCCCCATTCTCCTCCACA | - | 6.24 | ZNF263 | MA0528.1 | chr10:45871451-45871472 | GCTTCCTCCTCCCCATTCTCC | - | 6.25 | ZNF263 | MA0528.1 | chr10:45871454-45871475 | TCCTCCTCCCCATTCTCCTCC | - | 8.58 |
|
| Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
SE_09399 | chr10:45868709-45881193 | CD14 | SE_58689 | chr10:45850992-45873585 | Ly1 | SE_60844 | chr10:45863383-45873462 | DHL6 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 4 | Chromosome | Start | End |
chr10 | 45871250 | 45871727 | chr10 | 45871812 | 45872309 | chr10 | 45871674 | 45871974 | chr10 | 45871800 | 45872400 |
|
Enhancer Sequence | GTAGCACGAC ATGGCCCTCA GCCAAGTTCA CTAGCATCCT GGCTTGAGCT CCCTTCAAGA 60 AGAGTTAGGT GTTGAGTACA AGAGCAACCT TCAGTTGCTT AGTTGCCCCA GTCGGGGAAC 120 TGACCCTGAG GACTGCGGTG CCCTGGAGTT AATGTGTCGT CCATTTAGGG TGATGGCACC 180 CTCTGCCATT TCTGACGCAC CTTCATTTAC TTCCATTATT TCATGGATTC CCCACACCTG 240 GGGGAGAAGG ACAGGGTACA GGCTACTTCC CCTTTGTAAG TGCTTCCTCC TCCCCATTCT 300 CCTCCACACA TCATAAGGTT CTAGAAGCAC AGGCCATTGG TGTGCTCACA CTGCACAGCA 360 CGGGCACCCC GTGTGTGCTT TCCTCCTGCA GGGGACATGA TAACGTGGCC ATAGCGGGCT 420 CTTCGGACAA AGAGTGAAGG CACTGTTTTG TCCACTATCT CCCTCTCTCG GTCTGTCTTC 480 CCCTACCCTG AGAAGTCATT CAAATGACAT TATAATTAAA CACCTCAGCC GGAATCCCAG 540 GGGCAAATTT CAGGAGAGAT TTGCATGTCA CATTTCCATT GGGTTGAGAG GGCTATAAGT 600 CAGGGGTGGG GCGGGGGGTG GTTGGGGGTG GGGGCTACCG CAGGGTGGGG AACCAGCTAA 660 GGCTGAAAGT TTCCTTGAAA AAATCAGCTT TTGAGAAAGT TCCTGTTGAT GCAAAGTTAC 720 TCAACACTTT CTCTTGCCCA GCCCAGAACT ACTTCCTCAT TCTCCCAGCT TGGTATCTGT 780 AAAGACAATC ATCCTTTTTG GGTAAAGGTA AAAGAGAAAC CCTAGAGGAA GTACTTGCTG 840 AGAAGACAAG GTTATCCCAT TTTACAGGGA AAAGTGTTAA AATCTGTATT GTTAACAGTA 900 GTAACGATAA CAATAACAAT AAAGGTATTT CCACACAATT TAATCATTTC CAAGTTATTG 960 GCAGGTCAAC ACCCCCCTCC TCCAGGGCAT AGTTCAGTCA AATAATGGAC AGGACTGATT 1020 TTTTCCTTGA TAAAGTGAGT CACAGGTCCC TTGTTATTCT CATCAGAGTT CCGCATAGTG 1080 ATTCAGTCAG GACTGGGAAT CAAGTCCTTC GCAGGTGGGA TTATCCTATA AACGGTTGTG 1140 TCTTCCTTGG CTCCTCACTG TCTGCTGGAG AAAGCCGGGA TCCTACACAG AATGGCCCTG 1200 TTTCCAGAGG CTAACCCAAG TCTAGGCAAA TTTAACAAGT TGATTTATTT CTTTAACTCT 1260 GTAAATTTAA AGTAATTCAG ATCGGATACG ATAACTGTAA CAGATCTGAA GATTTCTGAG 1320 AAATCTTAGT TGGCCCATTT CATTCTGTGC TGGTACTTTT AAGAAAGCTA AGGGCAATAG 1380 CGTGGTGTTT AATATATGAT ACTTGAATAT GTTCAACAAG TGTAGAAAAG TGTTATAATG 1440
|